Chapter 15
Pharmacotherapy of Depression and Anxiety Disorders
抑郁症:概述
Depression is a common mental illness that manifests as major depression, persistent depressive disorder, and bipolar I and II disorders.
It can be ...
抗抑郁药:概述
Antidepressant drugs alleviate symptoms of depression by enhancing neurotransmission in the brain.
These agents are classified based on their chemical ...
抗抑郁药:三环类药物、SSRI 类和 SNRI 类
Tricyclic antidepressants, or TCAs, are first-generation antidepressants.
They block serotonin and norepinephrine reuptake transporters while inhibiting ...
抗抑郁药:MAOI 和其他药物
Monoamine oxidase inhibitors, or MAOIs, inhibit monoamine oxidase, increasing neurotransmitter levels.
Atypical antidepressants encompass drugs with ...
帕金森病:概述
Neurodegenerative disorders are progressive conditions characterized by the irreversible loss of neurons in specific brain regions.
The primary ...
帕金森病:治疗
Parkinson's Disease or PD is a neurodegenerative disorder characterized by an imbalance between cholinergic and reduced dopaminergic neurons.
The ...
阿尔茨海默病:概述
Alzheimer's disease, or AD, is a neurodegenerative disorder primarily affecting older adults, causing impaired memory and cognitive decline through ...
阿尔茨海默病:治疗
The goal of Alzheimer's disease or AD pharmacotherapy is to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms, ...
版权所属 © 2025 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。